FDA Approves Drug Aimed at Preventing Respiratory Disease in Babies and Toddlers

A sign for the Food and Drug Administration outside the headquarters in White Oak, Md., on July 20, 2020. Sarah Silbiger/Getty Images

U.S. drug regulators have approved a drug aimed at preventing a respiratory disease in babies and toddlers.

The U.S. Food and Drug Administration (FDA) on July 17 cleared Beyfortus, a monoclonal antibody that prevents respiratory syncytial virus (RSV), a lower respiratory tract disease.